Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal Guam.
Press releases published on September 25, 2025
Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody
BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), today announces it will advance its second asset, a fully human anti-IL-6 receptor (“IL-6R”) monoclonal antibody, TZLS-501. There has been …
Commure Partners with Bethany Children’s Health Center to Help Reduce Clinician Documentation Burden and Enhance Productivity
MOUNTAIN VIEW, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Commure, a leading healthcare technology company, today announced a new partnership with Bethany Children’s Health Center, a MEDITECH-powered pediatric rehabilitation hospital and Oklahoma’s premier …
Pelayanan Kesehatan sebagai Investasi Paling Strategis di Dunia: CEO KFSHRC Menyerukan Kolaborasi Global di KTT C3 Jepang
TOKYO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Pelayanan kesehatan harus diakui sebagai investasi paling strategis di dunia untuk mencapai manfaat keamanan, kemakmuran, dan ketahanan—bukan sebagai beban finansial—demikian disampaikan oleh Yang Mulia Dr. Majid …
世界で最も戦略的な投資としての医療：KFSHRCのCEO、日本で開催されたC3サミットで国際協力を呼びかけ
東京発, Sept. 25, 2025 (GLOBE NEWSWIRE) -- 医療は、財政的負担ではなく、安全保障、繁栄、回復力に対する世界で最も戦略的な投資として認識されなければならない、とサウジアラビア王室顧問でありキング・ファイサル・スペシャリスト病院＆研究センター (King Faisal Specialist Hospital and Research Centre、KFSHRC) の最高経営責任者であるマジド・アルファイヤド博士 (H.E. Dr. Majid Alfayyadh) …
Penjagaan Kesihatan sebagai Pelaburan Strategik Terpenting Dunia: Ketua Pegawai Eksekutif KFSHRC Seru Kerjasama Global di Sidang Kemuncak C3 Jepun
TOKYO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Penjagaan kesihatan mesti diiktiraf sebagai pelaburan strategik paling penting dunia dalam aspek keselamatan, kemakmuran dan daya tahan—bukan sekadar beban kewangan—tegas YBhg. Dr. Majid Alfayyadh, Penasihat di …
การดูแลสุขภาพเป็นการลงทุนเชิงยุทธศาสตร์ที่สำคัญที่สุดของโลก: ประธานบริหาร KFSHRC เรียกร้องความร่วมมือระดับโลกในการประชุมสุดยอดญี่ปุ่น C…
โตเกียว, Sept. 25, 2025 (GLOBE NEWSWIRE) -- การดูแลสุขภาพต้องได้รับการยอมรับว่าเป็นการลงทุนเชิงยุทธศาสตร์ที่สำคัญที่สุดของโลกในด้านความมั่นคง ความเจริญรุ่งเรือง และความสามารถในการปรับตัวเพื่อรับมือกับสถานการณ์—ไม่ใช่ภาระทางการเงิน—ฯพณฯ ดร. Majid Alfayyadh …
킹 파이살 전문병원 겸 연구센터 (KFSHRC) CEO, , C3 일본 정상회의에서 글로벌 협력 촉구하며세계에서 가장 전략적인 투자로서의 의료가 갖는 가치 강조
도쿄, Sept. 25, 2025 (GLOBE NEWSWIRE) -- 사우디 왕실 자문이자 킹 파이살 전문병원 겸 연구센연구센터 (HRC) 최고경영자인 마지드 알파이야드(H.E. Dr. Majid Alfayyadh) 는 도쿄에서 열린 C3 다보스 헬스케어™ 정상회의 기조연설에서 “보건의료는 재정적 부담이 아니라, 안보·번영·회복력에 있어 세계에서 가장 전략적인 투자로 인식되어야 한다.”고 선언했다. 알파이야드 박사는 보건의료 체계에 대한 투자가 생명 …
Chicago's New Prenatal Education and Social Club Helps Parents Build Their Village
CHICAGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Parenthood changes everything, and while many new parents say they feel overwhelmed most days, it doesn’t have to mean doing it alone. This November, Expecting Together will debut in Chicago with a fresh take on …
Predictive Oncology Announces 1-for-15 Reverse Stock Split
PITTSBURGH, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI), a leader in AI-driven drug development and discovery, today announced that it will effect a 1-for-15 reverse stock split of its issued and outstanding shares of common …
Numab Therapeutics Achieves Milestone in Collaboration with Boehringer Ingelheim
Numab to receive first milestone payment Boehringer Ingelheim has advanced its novel tumor antigen targeting T cell engager resulting from a collaboration with Numab into preclinical development HORGEN, Switzerland, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Numab …
Kestra Showcases Cardiac Recovery System Platform at HFSA 2025, Redefining Sudden Cardiac Arrest Risk Management
KIRKLAND, Wash., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced its debut at the 2025 Heart Failure Society of America (HFSA) Annual Scientific …
ORYZON to Participate in Upcoming Events in September and October
MADRID and CAMBRIDGE, Mass., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its management will participate at …
Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings
LAGUNA HILLS, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced that it has acquired an additional 176,422 HYPE tokens, expanding its total holdings to 1,712,195 HYPE purchased …
Biolinq Shine™ Granted De Novo Classification by U.S. FDA for the First Fully Autonomous, Needle-Free Glucose Sensor
First glucose sensor with an integrated primary display that works with and without a phone Establishes a new category of wearable glucose sensors for metabolic health SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Biolinq Incorporated, a pioneering …
Solid Biosciences to Present at 2025 Neuromuscular Study Group Annual Scientific Meeting
CHARLESTOWN, Mass., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will present data from the Phase 1/2 INSPIRE DUCHENNE trial …
AI in Breast Imaging: New BreastCT.com Article Examines IzoView’s Competitive Edge
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging …
Nuvectis Pharma Appoints Biotech Executive Juan Sanchez, MD, to the Board of Directors
Fort Lee, NJ, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in …
Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients
Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis Across non-active progressive MS (primary progressive and secondary progressive MS), relapsing MS, and Parkinson’s disease …